IL88731A0 - Non-reverting rna viruses - Google Patents
Non-reverting rna virusesInfo
- Publication number
- IL88731A0 IL88731A0 IL88731A IL8873188A IL88731A0 IL 88731 A0 IL88731 A0 IL 88731A0 IL 88731 A IL88731 A IL 88731A IL 8873188 A IL8873188 A IL 8873188A IL 88731 A0 IL88731 A0 IL 88731A0
- Authority
- IL
- Israel
- Prior art keywords
- reverting
- rna viruses
- vaccines
- relates
- rna viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14250788A | 1988-01-11 | 1988-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL88731A0 true IL88731A0 (en) | 1989-07-31 |
Family
ID=22500099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL88731A IL88731A0 (en) | 1988-01-11 | 1988-12-20 | Non-reverting rna viruses |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0325768B1 (fi) |
JP (1) | JPH01222774A (fi) |
AT (1) | ATE121779T1 (fi) |
AU (1) | AU2833789A (fi) |
DE (1) | DE3853672T2 (fi) |
DK (1) | DK8789A (fi) |
ES (1) | ES2070846T3 (fi) |
FI (1) | FI890116A (fi) |
IL (1) | IL88731A0 (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286640A (en) * | 1988-01-05 | 1994-02-15 | Almond Jeffrey W | Attenuated polioviruses |
US5298416A (en) * | 1989-01-18 | 1994-03-29 | British Technology Group Ltd. | Attenuated polioviruses |
GB8901093D0 (en) * | 1989-01-18 | 1989-03-15 | Almond Jeffrey W | Attenuated viruses |
ATE132527T1 (de) * | 1989-06-08 | 1996-01-15 | American Cyanamid Co | Nicht-zurückmutierende rna-viren |
GB9107563D0 (en) * | 1991-04-10 | 1991-05-29 | Macadam Andrew J | Thermostable viruses |
GB9107552D0 (en) * | 1991-04-10 | 1991-05-29 | Macadam Andrew J | Attenuated viruses |
GB9705669D0 (en) * | 1997-03-19 | 1997-05-07 | British Tech Group | Attenuated polioviruses |
US6853093B2 (en) | 2002-12-20 | 2005-02-08 | Lipman Electronic Engineering Ltd. | Anti-tampering enclosure for electronic circuitry |
US8405506B2 (en) | 2010-08-02 | 2013-03-26 | Verifone, Inc. | Secure data entry device |
US8593824B2 (en) | 2010-10-27 | 2013-11-26 | Verifone, Inc. | Tamper secure circuitry especially for point of sale terminal |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4719177A (en) * | 1981-04-20 | 1988-01-12 | Massachusetts Institute Of Technology | Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor |
JPS59173084A (ja) * | 1982-11-30 | 1984-09-29 | インステイチユ−ト・パスツ−ル | ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するdna類 |
EP0156299A3 (en) * | 1984-03-26 | 1987-04-01 | Chiron Corporation | Ltr modified viral vaccines |
-
1988
- 1988-12-19 AT AT88121231T patent/ATE121779T1/de not_active IP Right Cessation
- 1988-12-19 EP EP88121231A patent/EP0325768B1/en not_active Expired - Lifetime
- 1988-12-19 DE DE3853672T patent/DE3853672T2/de not_active Expired - Fee Related
- 1988-12-19 ES ES88121231T patent/ES2070846T3/es not_active Expired - Lifetime
- 1988-12-20 IL IL88731A patent/IL88731A0/xx unknown
-
1989
- 1989-01-10 FI FI890116A patent/FI890116A/fi not_active Application Discontinuation
- 1989-01-10 JP JP1002171A patent/JPH01222774A/ja active Pending
- 1989-01-10 AU AU28337/89A patent/AU2833789A/en not_active Abandoned
- 1989-01-10 DK DK008789A patent/DK8789A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK8789D0 (da) | 1989-01-10 |
EP0325768A2 (en) | 1989-08-02 |
AU2833789A (en) | 1989-07-13 |
ES2070846T3 (es) | 1995-06-16 |
DE3853672D1 (de) | 1995-06-01 |
DK8789A (da) | 1989-07-12 |
FI890116A0 (fi) | 1989-01-10 |
FI890116A (fi) | 1989-07-12 |
EP0325768A3 (en) | 1989-08-30 |
DE3853672T2 (de) | 1996-01-11 |
JPH01222774A (ja) | 1989-09-06 |
EP0325768B1 (en) | 1995-04-26 |
ATE121779T1 (de) | 1995-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE129160T1 (de) | Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt. | |
AU5110490A (en) | Immunogenic regions on the e7 protein of human papillomavirus type 16 | |
FR09C0033I1 (fi) | ||
HK1002901A1 (en) | A composition used as a therapeutic agent against chronic viral hepatic diseases | |
PT84155A (en) | Method of modifying plant viruses or their effects | |
EP0325768A3 (en) | Non-reverting rna viruses | |
AR242057A1 (es) | Poliovirus quimerico viable, cdna recombinante hibrido apto para su produccion en un cultivo de celulas, y procedimiento para la obtencion de dicho poliovirus. | |
IE892565L (en) | Heparin fragments and fractions with anti-hiv action | |
CA2064029A1 (en) | Use of mycobacterium vaccae in the prevention of aids | |
ES8704962A1 (es) | Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida. | |
IL81568A0 (en) | Plasmids which inhibit human t-cell lymphotropic virus type iii replication | |
AU630099B2 (en) | Non-reverting rna viruses | |
AU7514087A (en) | Vaccine containing the protein f of the aids virus | |
AU653861B2 (en) | Respiratory disease vaccine for cats | |
FR2671974B1 (fi) | ||
LTIP1943A (en) | Arylating agents, used in the treatment of cancerand disease caused by viral infection | |
NO891355L (no) | Vaksinasjon mot rabis-beslektede virus. |